Table 1.
The demographic and clinical biochemical indicators of participants
| HC (n = 30) | CCQS (n = 44) | QSBS (n = 37) | p values | |
|---|---|---|---|---|
| Basic information | ||||
| Age (year) | 62.8 ± 9.4 | 67.2 ± 7.7 | 67.5 ± 7.8 | 0.048 |
| Female | 17 (56.7) | 25 (56.8) | 21 (56.8) | 1.000 |
| BMI (kg/m2) | 24.7 ± 2.9 | 24.1 ± 3.9 | 25.2 ± 3.3 | 0.367 |
| Arrhythmia | 6 (20) | 6 (13.6) | 6 (16.2) | 0.768 |
| Diabetes mellitus | 1 (3.3) | 20 (45.5) | 15 (40.5) | < 0.001 |
| Hypertension | 5 (16.7) | 28 (63.6) | 28 (75.7) | < 0.001 |
| Hyperlipidemia | 4 (13.3) | 26 (59.1) | 24 (64.9) | < 0.001 |
| Cerebrovascular disease | 2 (6.7) | 4 (9.1) | 15 (40.5) | < 0.001 |
| Laboratory data | ||||
| TC (mmol/L) | 5.2 ± 1.0 | 4.4 ± 1 | 4.3 ± 0.9 | 0.001 |
| TG (mmol/L) | 1.4 ± 0.9 | 1.5 ± 0.8 | 1.6 ± 0.7 | 0.704 |
| HDL (mmol/L) | 1.5 ± 0.3 | 1.2 ± 0.2 | 1.3 ± 0.3 | 0.005 |
| LDL (mmol/L) | 3.1 ± 0.8 | 2.6 ± 0.8 | 2.5 ± 0.7 | 0.002 |
| Albumin (g/L) | 44.0 ± 2.1 | 44.1 ± 2.7 | 45 ± 5.9 | 0.532 |
| ALP (U/L) | 89.9 ± 24.7 | 87.8 ± 20 | 86.4 ± 31.6 | 0.871 |
| ALT (U/L) | 20.4 ± 10.9 | 22.2 ± 12 | 21.3 ± 10.5 | 0.800 |
| AST (U/L) | 24.1 ± 5.1 | 24.5 ± 8.3 | 23.1 ± 6.1 | 0.665 |
| Creatinine (µmol/L) | 61.8 ± 11.3 | 65 ± 16.8 | 63.6 ± 16.5 | 0.694 |
| GGT (U/L) | 25.6 ± 16.9 | 29.5 ± 24.7 | 29.2 ± 17.4 | 0.717 |
| Glu (mmol/L) | 5.8 ± 1.2 | 6.8 ± 1.9 | 6.6 ± 1.7 | 0.03 |
| HCY (µmol/L) | 17.3 ± 13.5 | 14.9 ± 5.7 | 14.6 ± 5.3 | 0.377 |
| hs-CRP (mg/L) | 1.9 ± 2.1 | 2 ± 2.2 | 1.6 ± 1.9 | 0.666 |
| Total protein (g/L) | 74.4 ± 4.6 | 73.8 ± 4.7 | 73.4 ± 6.2 | 0.778 |
| Urea (mmol/L) | 5.2 ± 1.0 | 5.5 ± 2 | 5.9 ± 1.9 | 0.315 |
| Uric acid (µmol/L) | 305 ± 80.2 | 318.4 ± 79.9 | 344.3 ± 81 | 0.131 |
Values were mean ± SD or %; p values determined by one-way ANOVA and χ2 test